PFIZER INC · Drugmakers

PFE

Low riskNext report: In 7 days (est.)

View price ↗

The short version

A profitable company with steady sales.

Going well

Raised its dividend (5.8% yield)
Profitable every year for 10 years
Brings in more cash than it spends

Money moves

No insider buying or selling in the last 30 days
Institutions added 2.1% to their holdings in the quarter ending June 2026 (1263 bought, 1426 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$29.79-0.8% that day

Company value: $169.8B; Share price times all shares
Price vs profit (P/E): 39.2x; You pay about $39 for each $1 of yearly profit
Price vs sales: 2.7x; Company value is 2.7 times a year of sales
Dividend yield: 5.8%; Yearly dividend as a share of today's price
Cash vs value: 1%; Cash as a share of company value
Debt vs value: 38%; Debt as a share of company value

From PFE's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$15.0B+2.6% vs a year earlier

Oct '23Tap a barJun '26

Last 12 months: $63.7B, down 0.2% from the 12 months before. Over 5 years, sales grew about 8.5% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of PFE. Starting points are the company's recent numbers.

Sales growth0% a yearRecently: -0.2% a yearProfit margin7%Last 12 months: 6.8%P/E at the end39xToday: 39.2x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$63.7B

Profit in 5 years$4.5B

Price these guesses point to$30.51+2.4% vs $29.79 todayAbout +0.5% a year, before dividends

What today's price needs: with a 7% margin and a 39x P/E, sales could shrink about 0.5% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/6Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.8.9%
MissDebt under half of equityNot relying on borrowed money.0.75x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.12.4%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$9.1B
PassShare count not growingNot diluting owners. Falling means buybacks.-0.3% in 3 years

Revenue: $62.6B; -1.6% vs prior year
5-year growth: +8.5%/yr; revenue, per year
Total debt: $64.6B; 0.75x equity
Current ratio: 1.16x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 28, 2026

Reported Aug 4

Revenue: $15.0B; +2.6% YoY
EPS: -$0.04; vs $0.51
Gross margin: 72.8%; -1.4 pts
Free cash flow: $302.0M
Share count: -0.1%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.8
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+2.1%

Institutions added 2.1% to their holdings. 1263 bought, 1426 sold. 3 quarters of net buying in a row.

Shares held by institutions3.83B

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+0.3%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.7x · $63.1B debt

Shares outstandingLatest reported

5.7B

Earnings reports

Last 12

Next reportIn 7 days (est.)Estimated from the same quarter last year

Results filedAug 4
Results filedMay 5
Results filedFeb 3
Results filedNov 4, 2025
Results filedAug 5, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

New 5%+ holder (passive)Oct 16 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

New 5%+ holder (passive)Oct 16 · Form SCHEDULE 13G ↗

Stock awardAlbert BourlaChairman & CEO, Director

20 shares at $29.44 · $589

+0% of holdings
Now owns 783,997 shares
Phantom Stock Units SSP
Filed 1 day after trade

Oct 15Form 4 ↗

Stock awardAlbert BourlaChairman & CEO, Director

71 shares at $28.37 · $2K

+0% of holdings
Now owns 783,981 shares
Phantom Stock Units SSP
Filed 1 day after trade

Oct 13Form 4 ↗

Stock awardAlbert BourlaChairman & CEO, Director

21 shares at $28.52 · $599

+0% of holdings
Now owns 783,888 shares
Phantom Stock Units SSP
Filed 1 day after trade

Sep 30Form 4 ↗

Stock awardCyrus TaraporevalaDirector

1,308 shares at $28.67 · $38K

+3% of holdings
Now owns 38,806 shares
Phantom Stock Units
Filed 4 days after trade

Sep 25Form 4 ↗

Stock awardJames C SmithDirector

1,570 shares at $28.67 · $45K

+1% of holdings
Now owns 187,210 shares
Phantom Stock Units
Filed 4 days after trade

Sep 25Form 4 ↗

Stock awardJames QuinceyDirector

1,352 shares at $28.67 · $39K

+2% of holdings
Now owns 90,671 shares
Phantom Stock Units
Filed 4 days after trade

Sep 25Form 4 ↗

Insider tradeSep 29 · Form 4 ↗Insider tradeSep 29 · Form 4 ↗Insider tradeSep 29 · Form 4 ↗Insider tradeSep 16 · Form 4 ↗Insider tradeSep 1 · Form 4 ↗N-PXAug 31 · Form N-PX ↗New insiderAug 28 · Form 3 ↗Insider tradeAug 17 · Form 4 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page